 | • レポートコード：MRC2-11QY11165 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は骨転移治療薬のグローバル市場について調査・分析したレポートです。種類別（薬物治療、腫瘍アブレーション療法、手術）市場規模、用途別（病院、がんリハビリセンター、専門クリニック、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別骨転移治療薬の競争状況、市場シェア ・世界の骨転移治療薬市場：種類別市場規模 2015年-2020年（薬物治療、腫瘍アブレーション療法、手術） ・世界の骨転移治療薬市場：種類別市場規模予測 2021年-2026年（薬物治療、腫瘍アブレーション療法、手術） ・世界の骨転移治療薬市場：用途別市場規模 2015年-2020年（病院、がんリハビリセンター、専門クリニック、外来手術センター） ・世界の骨転移治療薬市場：用途別市場規模予測 2021年-2026年（病院、がんリハビリセンター、専門クリニック、外来手術センター） ・北米の骨転移治療薬市場分析：米国、カナダ ・ヨーロッパの骨転移治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの骨転移治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の骨転移治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの骨転移治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：F. Hoffmann-La Roche、Bayer、Merck、Pfizer、Novartis、Amgen、Pharmalucence、Fresenius Kabi、Omega Laboratories、Eli Lilly ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bone metastasis is the third most common condition in metastatic cancers and occurs in 60-65% of patients with metastatic cancers. The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic cancers are rarely able to be cured, and treatment of bone metastasis involves medications to shrink, stop or slow down the growth of the tumor. Treatment options available for bone metastasis are symptomatic treatments which are meant for pain control, treatment, and prevention of fractures, improvement in functional disability, etc. Randomized trials on metastatic patients by UBM Medica, LLC showed that 45-75% patients develop functional disability every 3-4 months, 10-15% patients develop hypercalcemia and 10-20% patients develop long bone fractures.
Treatment of bone metastasis is the interdisciplinary field involving pain management, orthopedics, and other medical specialties. Primary factors driving the growth of bone metastasis therapeutics market are the global increase in cancer prevalence and delayed diagnosis of cancer in low-income countries. According to University of Texas Southwestern Medical Center Dallas, over 600,000 of bone metastasis are diagnosed in the U.S. every year. Rapid innovation in the field of personalized medicine and identification of new therapeutic targets for bone metastasis presents a huge opportunity to manufacturers of targeted therapy agents. A large number of treatment methods are still under investigation. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global bone metastasis therapeutics market.
Market Analysis and Insights: Global Bone Metastasis Therapeutics Market
The global Bone Metastasis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bone Metastasis Therapeutics Scope and Market Size
Bone Metastasis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bone Metastasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
F. Hoffmann-La Roche
Bayer
Merck
Pfizer
Novartis
Amgen
Pharmalucence
Fresenius Kabi
Omega Laboratories
Eli Lilly
Market segment by Type, the product can be split into
Drug Treatment
Tumor Ablation Therapy
Surgery
Market segment by Application, split into
Hospitals
Cancer Rehabilitation Centers
Specialty Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bone Metastasis Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Bone Metastasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drug Treatment
1.4.3 Tumor Ablation Therapy
1.4.4 Surgery
1.5 Market by Application
1.5.1 Global Bone Metastasis Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Cancer Rehabilitation Centers
1.5.4 Specialty Clinics
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bone Metastasis Therapeutics Market Perspective (2015-2026)
2.2 Global Bone Metastasis Therapeutics Growth Trends by Regions
2.2.1 Bone Metastasis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bone Metastasis Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Bone Metastasis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bone Metastasis Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Bone Metastasis Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bone Metastasis Therapeutics Players by Market Size
3.1.1 Global Top Bone Metastasis Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Bone Metastasis Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Bone Metastasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bone Metastasis Therapeutics Market Concentration Ratio
3.2.1 Global Bone Metastasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bone Metastasis Therapeutics Revenue in 2019
3.3 Bone Metastasis Therapeutics Key Players Head office and Area Served
3.4 Key Players Bone Metastasis Therapeutics Product Solution and Service
3.5 Date of Enter into Bone Metastasis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bone Metastasis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Bone Metastasis Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bone Metastasis Therapeutics Market Size by Application (2015-2020)
5.2 Global Bone Metastasis Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bone Metastasis Therapeutics Market Size (2015-2020)
6.2 Bone Metastasis Therapeutics Key Players in North America (2019-2020)
6.3 North America Bone Metastasis Therapeutics Market Size by Type (2015-2020)
6.4 North America Bone Metastasis Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bone Metastasis Therapeutics Market Size (2015-2020)
7.2 Bone Metastasis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Bone Metastasis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Bone Metastasis Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Bone Metastasis Therapeutics Market Size (2015-2020)
8.2 Bone Metastasis Therapeutics Key Players in China (2019-2020)
8.3 China Bone Metastasis Therapeutics Market Size by Type (2015-2020)
8.4 China Bone Metastasis Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bone Metastasis Therapeutics Market Size (2015-2020)
9.2 Bone Metastasis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Bone Metastasis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Bone Metastasis Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bone Metastasis Therapeutics Market Size (2015-2020)
10.2 Bone Metastasis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bone Metastasis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Bone Metastasis Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Bone Metastasis Therapeutics Market Size (2015-2020)
11.2 Bone Metastasis Therapeutics Key Players in India (2019-2020)
11.3 India Bone Metastasis Therapeutics Market Size by Type (2015-2020)
11.4 India Bone Metastasis Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bone Metastasis Therapeutics Market Size (2015-2020)
12.2 Bone Metastasis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Bone Metastasis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Bone Metastasis Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Details
13.1.2 F. Hoffmann-La Roche Business Overview
13.1.3 F. Hoffmann-La Roche Bone Metastasis Therapeutics Introduction
13.1.4 F. Hoffmann-La Roche Revenue in Bone Metastasis Therapeutics Business (2015-2020))
13.1.5 F. Hoffmann-La Roche Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Bone Metastasis Therapeutics Introduction
13.2.4 Bayer Revenue in Bone Metastasis Therapeutics Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Bone Metastasis Therapeutics Introduction
13.3.4 Merck Revenue in Bone Metastasis Therapeutics Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Bone Metastasis Therapeutics Introduction
13.4.4 Pfizer Revenue in Bone Metastasis Therapeutics Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Bone Metastasis Therapeutics Introduction
13.5.4 Novartis Revenue in Bone Metastasis Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Bone Metastasis Therapeutics Introduction
13.6.4 Amgen Revenue in Bone Metastasis Therapeutics Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Pharmalucence
13.7.1 Pharmalucence Company Details
13.7.2 Pharmalucence Business Overview
13.7.3 Pharmalucence Bone Metastasis Therapeutics Introduction
13.7.4 Pharmalucence Revenue in Bone Metastasis Therapeutics Business (2015-2020)
13.7.5 Pharmalucence Recent Development
13.8 Fresenius Kabi
13.8.1 Fresenius Kabi Company Details
13.8.2 Fresenius Kabi Business Overview
13.8.3 Fresenius Kabi Bone Metastasis Therapeutics Introduction
13.8.4 Fresenius Kabi Revenue in Bone Metastasis Therapeutics Business (2015-2020)
13.8.5 Fresenius Kabi Recent Development
13.9 Omega Laboratories
13.9.1 Omega Laboratories Company Details
13.9.2 Omega Laboratories Business Overview
13.9.3 Omega Laboratories Bone Metastasis Therapeutics Introduction
13.9.4 Omega Laboratories Revenue in Bone Metastasis Therapeutics Business (2015-2020)
13.9.5 Omega Laboratories Recent Development
13.10 Eli Lilly
13.10.1 Eli Lilly Company Details
13.10.2 Eli Lilly Business Overview
13.10.3 Eli Lilly Bone Metastasis Therapeutics Introduction
13.10.4 Eli Lilly Revenue in Bone Metastasis Therapeutics Business (2015-2020)
13.10.5 Eli Lilly Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bone Metastasis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Bone Metastasis Therapeutics Revenue
Table 3. Ranking of Global Top Bone Metastasis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bone Metastasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug Treatment
Table 6. Key Players of Tumor Ablation Therapy
Table 7. Key Players of Surgery
Table 8. Global Bone Metastasis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Bone Metastasis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Bone Metastasis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Bone Metastasis Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Bone Metastasis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Bone Metastasis Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Bone Metastasis Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Bone Metastasis Therapeutics Players
Table 19. Global Bone Metastasis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Bone Metastasis Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Bone Metastasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Metastasis Therapeutics as of 2019)
Table 22. Global Bone Metastasis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Bone Metastasis Therapeutics Product Solution and Service
Table 25. Date of Enter into Bone Metastasis Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Bone Metastasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Bone Metastasis Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Bone Metastasis Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Bone Metastasis Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Bone Metastasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Bone Metastasis Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Bone Metastasis Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Bone Metastasis Therapeutics Market Share (2019-2020)
Table 35. North America Bone Metastasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Bone Metastasis Therapeutics Market Share by Type (2015-2020)
Table 37. North America Bone Metastasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Bone Metastasis Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Bone Metastasis Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Bone Metastasis Therapeutics Market Share (2019-2020)
Table 41. Europe Bone Metastasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Bone Metastasis Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Bone Metastasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Bone Metastasis Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Bone Metastasis Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Bone Metastasis Therapeutics Market Share (2019-2020)
Table 47. China Bone Metastasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Bone Metastasis Therapeutics Market Share by Type (2015-2020)
Table 49. China Bone Metastasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Bone Metastasis Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Bone Metastasis Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Bone Metastasis Therapeutics Market Share (2019-2020)
Table 53. Japan Bone Metastasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Bone Metastasis Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Bone Metastasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Bone Metastasis Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Bone Metastasis Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Bone Metastasis Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Bone Metastasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Bone Metastasis Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Bone Metastasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Bone Metastasis Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Bone Metastasis Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Bone Metastasis Therapeutics Market Share (2019-2020)
Table 65. India Bone Metastasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Bone Metastasis Therapeutics Market Share by Type (2015-2020)
Table 67. India Bone Metastasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Bone Metastasis Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Bone Metastasis Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Bone Metastasis Therapeutics Market Share (2019-2020)
Table 71. Central & South America Bone Metastasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Bone Metastasis Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Bone Metastasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Bone Metastasis Therapeutics Market Share by Application (2015-2020)
Table 75. F. Hoffmann-La Roche Company Details
Table 76. F. Hoffmann-La Roche Business Overview
Table 77. F. Hoffmann-La Roche Product
Table 78. F. Hoffmann-La Roche Revenue in Bone Metastasis Therapeutics Business (2015-2020) (Million US$)
Table 79. F. Hoffmann-La Roche Recent Development
Table 80. Bayer Company Details
Table 81. Bayer Business Overview
Table 82. Bayer Product
Table 83. Bayer Revenue in Bone Metastasis Therapeutics Business (2015-2020) (Million US$)
Table 84. Bayer Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Bone Metastasis Therapeutics Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Product
Table 93. Pfizer Revenue in Bone Metastasis Therapeutics Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Bone Metastasis Therapeutics Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Product
Table 103. Amgen Revenue in Bone Metastasis Therapeutics Business (2015-2020) (Million US$)
Table 104. Amgen Recent Development
Table 105. Pharmalucence Company Details
Table 106. Pharmalucence Business Overview
Table 107. Pharmalucence Product
Table 108. Pharmalucence Revenue in Bone Metastasis Therapeutics Business (2015-2020) (Million US$)
Table 109. Pharmalucence Recent Development
Table 110. Fresenius Kabi Business Overview
Table 111. Fresenius Kabi Product
Table 112. Fresenius Kabi Company Details
Table 113. Fresenius Kabi Revenue in Bone Metastasis Therapeutics Business (2015-2020) (Million US$)
Table 114. Fresenius Kabi Recent Development
Table 115. Omega Laboratories Company Details
Table 116. Omega Laboratories Business Overview
Table 117. Omega Laboratories Product
Table 118. Omega Laboratories Revenue in Bone Metastasis Therapeutics Business (2015-2020) (Million US$)
Table 119. Omega Laboratories Recent Development
Table 120. Eli Lilly Company Details
Table 121. Eli Lilly Business Overview
Table 122. Eli Lilly Product
Table 123. Eli Lilly Revenue in Bone Metastasis Therapeutics Business (2015-2020) (Million US$)
Table 124. Eli Lilly Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bone Metastasis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Drug Treatment Features
Figure 3. Tumor Ablation Therapy Features
Figure 4. Surgery Features
Figure 5. Global Bone Metastasis Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Cancer Rehabilitation Centers Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Bone Metastasis Therapeutics Report Years Considered
Figure 11. Global Bone Metastasis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Bone Metastasis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Bone Metastasis Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Bone Metastasis Therapeutics Market Share by Players in 2019
Figure 16. Global Top Bone Metastasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Metastasis Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Bone Metastasis Therapeutics Revenue in 2019
Figure 18. North America Bone Metastasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Bone Metastasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Bone Metastasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Bone Metastasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Bone Metastasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Bone Metastasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Bone Metastasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
骨肉腫診断・治療の世界市場（～2026年） Bone cancer is a malignant tumor that arises from the cells that make up the bones of the body. Robust healthcare expenditure in developed countries, genetic disorder, and development of stem cell transplant technology are some of the major factors that drive the growth of the market. Rising geriatr…- 骨髄移植拒絶反応治療の世界市場（～2026年） Market Analysis and Insights: Global Bone Marrow Transplant Rejection Treatment Market The global Bone Marrow Transplant Rejection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Bone Marrow Transplant Reject…
- 消退骨病の世界市場（～2026年） Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteo…
- 脳腫瘍治療薬の世界市場（～2026年） A brain tumor occurs when abnormal cells form within the brain. North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics mark…
- 骨・ミネラル代謝障害治療の世界市場（～2026年） Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone re…